| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
|
Chao, Yee
|
|
2014
|
73 |
4 |
p. 799-806
|
artikel
|
| 2 |
A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere
|
Soares, Heloisa P.
|
|
2014
|
73 |
4 |
p. 839-845
|
artikel
|
| 3 |
A prospective phase II trial of S-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer
|
Chang, Hyun
|
|
2014
|
73 |
4 |
p. 665-671
|
artikel
|
| 4 |
Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients
|
Han, Fei-fei
|
|
2014
|
73 |
4 |
p. 779-788
|
artikel
|
| 5 |
BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy
|
Foedermayr, Mathilde
|
|
2014
|
73 |
4 |
p. 771-778
|
artikel
|
| 6 |
Clinical pharmacokinetics of Icotinib, an anti-cancer drug: evaluation of dose proportionality, food effect, and tolerability in healthy subjects
|
Liu, Dongyang
|
|
2014
|
73 |
4 |
p. 721-727
|
artikel
|
| 7 |
Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure
|
Rudek, Michelle A.
|
|
2014
|
73 |
4 |
p. 729-736
|
artikel
|
| 8 |
Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib
|
Kalykaki, Antonia
|
|
2014
|
73 |
4 |
p. 685-693
|
artikel
|
| 9 |
Figitumumab in patients with refractory metastatic colorectal cancer previously treated with standard therapies: a nonrandomized, open-label, phase II trial
|
Becerra, Carlos R.
|
|
2014
|
73 |
4 |
p. 695-702
|
artikel
|
| 10 |
Overexpression of MET is a new predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS
|
Kishiki, Tomokazu
|
|
2014
|
73 |
4 |
p. 749-757
|
artikel
|
| 11 |
Paris Saponin II suppresses the growth of human ovarian cancer xenografts via modulating VEGF-mediated angiogenesis and tumor cell migration
|
Xiao, Xue
|
|
2014
|
73 |
4 |
p. 807-818
|
artikel
|
| 12 |
Perifosine inhibits S6K1–Gli1 signaling and enhances gemcitabine-induced anti-pancreatic cancer efficiency
|
Xin, Ying
|
|
2014
|
73 |
4 |
p. 711-719
|
artikel
|
| 13 |
Pharmacokinetics of doxorubicin in pregnant women
|
Ryu, Rachel J.
|
|
2014
|
73 |
4 |
p. 789-797
|
artikel
|
| 14 |
Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer
|
Mukai, Hirofumi
|
|
2014
|
73 |
4 |
p. 703-710
|
artikel
|
| 15 |
Phase II clinical trial of PM00104 (Zalypsis®) in urothelial carcinoma patients progressing after first-line platinum-based regimen
|
Castellano, Daniel E.
|
|
2014
|
73 |
4 |
p. 857-867
|
artikel
|
| 16 |
Phase 1 study of pazopanib alone or combined with lapatinib in Japanese patients with solid tumors
|
Inada-Inoue, Megumi
|
|
2014
|
73 |
4 |
p. 673-683
|
artikel
|
| 17 |
Population pharmacokinetics and exposure–response analyses of trastuzumab in patients with advanced gastric or gastroesophageal junction cancer
|
Cosson, Valérie F.
|
|
2014
|
73 |
4 |
p. 737-747
|
artikel
|
| 18 |
Population pharmacokinetics of afatinib, an irreversible ErbB family blocker, in patients with various solid tumors
|
Freiwald, Matthias
|
|
2014
|
73 |
4 |
p. 759-770
|
artikel
|
| 19 |
Salvage chemotherapy with docetaxel and pegylated liposomal doxorubicin in pretreated patients with platinum- and taxane-sensitive ovarian cancer: a multicenter phase II trial of the Hellenic Oncology Research Group (HORG)
|
Koinis, Filippos
|
|
2014
|
73 |
4 |
p. 819-825
|
artikel
|
| 20 |
Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics
|
Stoehr, Matthaeus
|
|
2014
|
73 |
4 |
p. 827-837
|
artikel
|
| 21 |
The impact of dose/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancer
|
Nakayama, Goro
|
|
2014
|
73 |
4 |
p. 847-855
|
artikel
|
| 22 |
The interactions of lenalidomide with human uptake and efflux transporters and UDP-glucuronosyltransferase 1A1: lack of potential for drug–drug interactions
|
Tong, Zeen
|
|
2014
|
73 |
4 |
p. 869-874
|
artikel
|
| 23 |
Therapy resistance mechanisms in Ewing’s sarcoma family tumors
|
Ahmed, Atif A.
|
|
2014
|
73 |
4 |
p. 657-663
|
artikel
|
Tijdschrift beschrijving